Wanbury Ltd share price logo

Wanbury Ltd Share Price(WANBURY)

Check the latest share price of Wanbury Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹304.859.83%

as on 04:01PM, 16 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Wanbury Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹301.2
    Day's Price Range
    ₹329.7
  • 52 Week's Low

    52 Week's High

    ₹131.2
    52-Week Price Range
    ₹329.7
1 Month Return+ 15.71 %
3 Month Return+ 44.67 %
1 Year Return+ 93.56 %
3 Year Return+ 330.28 %
5 Year Return+ 1632.1 %
Previous Close₹277.56
Open₹323.00
Volume25.59L
Upper Circuit₹333.07
Lower Circuit₹222.04

Wanbury Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹999.01 Cr

Return on Equity (ROE)

38.26

PE Ratio (TTM)

32.71

Return on capital employed (ROCE)

32.14

Industry PE ratio

55.34

Beta (LTM)

1.32

P/B Ratio

21.77

Dividend Yield

0

PEG Ratio

-4.2

Quarterly Earnings Growth YOY

-39.76

EPS (TTM)

17.09

Sector

Pharmaceuticals

Book Value

6.7

Technical Analysis

How to invest in Wanbury Ltd?

Investing in Wanbury Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Wanbury Ltd or WANBURY on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Wanbury Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Wanbury Ltd with just a few clicks!

Wanbury Ltd Stock's Interest Amongst Investors

120.39%

Period May 17, 2025 to Apr 17, 2025. Change in 30 Days vs previous period

Investment in Wanbury Ltd Shares on INDmoney has grown by 120.39% over the past 30 days, indicating increased transactional activity.

5%

Period May 17, 2025 to Apr 17, 2025. Change in 30 Days vs previous period

Search interest for Wanbury Ltd Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Wanbury Ltd Valuation

Track how the P/E of Wanbury Ltd has moved over time to understand valuation trends.

Wanbury Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-105.12x)

July 15, 2021

Today (32.71x)

May 16, 2025

Industry (55.34x)

May 16, 2025

Highest (146.91x)

September 29, 2023

LowHigh

Today’s Price to Earnings Ratio: 32.71x

Wanbury Ltd Financials

Get the annual and quarterly financial summary of Wanbury Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue

(in ₹ Cr)

139 (0%)131 (6%)161 (23%)133 (17%)172 (29%)
Net Income

(in ₹ Cr)

34 (0%)1 (97%)8 (671%)1 (85%)20 (1561%)
Net Profit Margin24.12% (0%)0.79% (97%)4.98% (530%)0.91% (82%)11.78% (1195%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

288 (0%)351 (22%)302 (14%)343 (14%)
Total Liabilities

(in ₹ Cr)

418 (0%)349 (17%)309 (11%)316 (2%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

44 (0%)17 (62%)41 (143%)20 (51%)4 (80%)

Wanbury Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Wanbury Ltd.

  • Wanbury Ltd Earnings Results

    Wanbury Ltd’s net profit fell -39.76% since last year same period to ₹20.26Cr in the Q4 2024-2025. On a quarterly growth basis, Wanbury Ltd has generated 1560.66% jump in its net profits since last 3-months.

    Read More about Earnings Results

Wanbury Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Wanbury Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
39.76%
0.00
Foreign Institutions
1.55%
0.00
Mutual Funds
0%
0.00
Retail Investors
58.68%
0.00
Others
0%
0.00

Wanbury Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Wanbury Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA999.01326.42%0.9155575
NA1,390.7377.48%0.6243381
NA161.48122.75%0.69753
NA691.09102.51%0.6211153
BUY15,063.4128.56%0.57726,702

Wanbury Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Wanbury Ltd.

  • Wanbury Reports Decline in Net Profit for March Quarter - 16 May, 2025

    Wanbury's consolidated net profit fell 39.76% to Rs 20.26 crore in Q1 March 2025, despite a 23.38% increase in sales to Rs 172 crore. For the full year, net profit declined 45.44% to Rs 30.53 crore, while sales rose 4.14% to Rs 599.51 crore.
  • Expert Chemicals Confirms No New Share Encumbrances - 20 Apr, 2025

    Expert Chemicals, a promoter of Wanbury Limited, announced no new share encumbrances for FY 2025, ensuring compliance with SEBI regulations and reinforcing market transparency.

Insights on Wanbury Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WANBURY has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, WANBURY stock has moved up by 15.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 134.29 Cr → 173.84 Cr (in ₹), with an average increase of 22.8% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.84% to 1.55% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 1.22 Cr → 20.26 Cr (in ₹), with an average increase of 94.0% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 39.76% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 59.40% to 58.68% in Mar 2025 quarter

About Wanbury Ltd

Wanbury Ltd Formerly known Pearl Organics Limited was incorporated in August 1988. The Company is engaged in the business of pharmaceutical and related activities including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995 the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996 it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 200708 the merger of Doctors Organic Chemicals Limited DOCL with the Company became effective from 1st April 2007. Pursuant to the aforesaid Order of the Honble Bl FR 785557 Equity Shares of face value of Rs. 10/ each of the Company were issued to the Equity Shareholders of DOCL on 17th March 2008. Similarly the Pharmaceutical Products of India Limited PPIL was merged with the Company effective from April 1 2006. In terms of the said Scheme of Merger the Company had issued 562618 Equity Shares of face value of Rs. 10/ each to the Equity Shareholders of PPIL on 27 June 2007 which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in ZurichSwitzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.The novel product Cdense Gems was launched in May 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched MyotolF targeted at female infertility in 2013 it launched Folinine. The Companys newly launched products MyotolF to treat polycystic ovarian syndrome and CalK2 in prevention and management of Osteoporosis were labelled as one of the best launches in 2014..

Revenue: ₹172.00Cr as on March 2025 (Q1 25)
Net Profit: ₹20.26Cr as on March 2025 (Q1 25)
Listing date: 29 Jan, 2007
Chairperson Name: K Chandran
OrganisationWanbury Ltd
IndustryPharmaceuticals
CEOK Chandran
E-voting on sharesClick here to vote

FAQs

What is Wanbury Ltd price today?

Wanbury Ltd share price today stands at ₹304.85, Open: ₹323, Previous Close: ₹277.56, High: ₹329.7, Low: ₹301.2, 52 Week High: ₹329.7, 52 Week Low: ₹131.2.

How to Buy Wanbury Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Wanbury Ltd shares

What are today's traded volumes of Wanbury Ltd?

Today's traded volume of Wanbury Ltd(WANBURY) is 25.59L.

What is today's market capitalisation of Wanbury Ltd?

Today's market capitalisation of Wanbury Ltd(WANBURY) is ₹999.01 Cr.

What is the 52 Week High and Low Range of Wanbury Ltd?

Wanbury Ltd (WANBURY)
Price
52 Week High
₹329.7
52 Week Low
₹131.2

How much percentage Wanbury Ltd is down from its 52 Week High?

Wanbury Ltd (WANBURY) share price is ₹304.85. It is down -7.54% from its 52 Week High price of ₹329.7

How much percentage Wanbury Ltd is up from its 52 Week low?

Wanbury Ltd (WANBURY) share price is ₹304.85. It is up 132.36% from its 52 Week Low price of ₹131.2